Targeting the PBX1-BCL2L1 axis as a therapeutic strategy in colorectal cancer.

Cell Death Discov · 2026 · PMC13287496 · PMID 42086530

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

did not reach statistical significanceP = 0.083so close (0.05 < p ≤ 0.1)

1G-J ): In CMS1, patients with low PBX1 expression tended to have poorer overall survival, although the difference did not reach statistical significance ( P = 0.083), suggesting a potential link between PBX1 downregulation and immune-related tumor progression.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.